Vaccine Therapy in Treating Patients With Multiple Myeloma

Clinical trial NCT00019097 · COMPLETED

Trial details

NCT number: NCT00019097
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II Multiple Myeloma Stage III Multiple Myeloma Refractory Plasma Cell Neoplasm

Start date: 1995-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.